Clinical Trials Browser

OTHER × Advanced Cancer × Magnetic Resonance Spectroscopy × Clear all

NCT01143779 2022-01-04

FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib

Phase 1 Completed

Advanced Cancer

NCT00610493 2017-12-08

Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

Phase 1 Completed

Advanced Cancer